Advertisement

Picture [iito] Back into Ad 650x80px
Document › Details

Abivax S.A.. (7/23/21). "Press Release: Abivax Announces the Pricing of Its Oversubscribed Capital Increase of EUR 60M and Convertible Bonds of EUR 25M, Totaling EUR 85M New Financing". Paris.

Organisations Organisation Abivax S.A. (Euronext Paris: ABVX)
  Group Abivax (Group)
  Organisation 2 Truffle Capital (FR)
Products Product ABX464 (Abivax)
  Product 2 ABX196 (Abivax)
Index terms Index term Abivax–SEVERAL: investment, 202107 capital increase €60m with 3% discount with 1.97m shares at €30.55/share
  Index term 2 Abivax–SEVERAL: credit, 202107– convertible bonds €25m at 6% interest/year
Persons Person Ehrlich, Hartmut J. (Abivax 201410 CEO before Baxter BioScience 200712 VP Global RnD)
  Person 2 Blondel, Didier (Abivax 201701– CFO before Sanofi Pasteur MSD + Sanofi)
     


   
Record changed: 2022-02-05

Advertisement

Picture [iito] Männer Ballett 650x100px

More documents for Abivax (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px




» top